News Release

CME Group Sets OTC Clearing Volume Record for the Fourth Consecutive Month, Surpasses $150 Billion in Total Notional Cleared

Mon Dec 05 2011

CHICAGO, Dec. 5, 2011 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today announced that it set new monthly records for clearing interest rate swaps (IRS) and credit default swaps (CDS).  For the month of November, the company cleared $61.9 billion in combined OTC IRS and CDS volume, a 36 percent increase over the previous record monthly total of $45.5 billion set in October 2011. 

As of November 30, 2011, the company has cleared more than $153 billion in OTC IRS and CDS through its multi-asset class clearing solution since launch, including over $130 billion of buy side notional.  Additionally, open interest stood at $115.7 billion in IRS and $15.9 billion in CDS.

The company also announced the strong performance of its newly launched OTC products, including Euro-denominated IRS which has cleared euro 27.6 billion since it launched on October 17, and the CDX High Yield Indices which have cleared $2.3 billion since they launched on November 7.   CME Group further expanded its IRS offering today, with the launch of British Pound and Canadian dollar-denominated IRS. 

"We are very pleased with the strong support we're receiving from buy side firms solidifying our position as the leading OTC clearing service by U.S. customer volume," said Laurent Paulhac, CME Group Managing Director, OTC Products & Services. "We continue to aggressively expand our product offering based on specific client demand. The success of our new IRS and CDS products validates our customer driven approach to building out our multi-asset class solution."

"Goldman Sachs is pleased to partner with CME Group in order to serve our clients as both an execution counterparty and clearing member for CME's OTC products," said Michael Dawley, Co-Head of Global Derivative Clearing Services at Goldman Sachs.  "CME's recent increase in customer volume illustrates the buy side's desire to leverage OTC clearing. Goldman Sachs is firmly committed to supporting our clients' OTC derivatives clearing needs, and will continue to work with CME Group to build out its OTC clearing business." 

"RBS plc is pleased to have garnered the leadership role of the first bank approved by the CME as a direct clearing member for OTC derivatives," said Henson Orser, Head of USD Rates Sales. "We are very supportive of the early adopters that use the CME to reduce bilateral counterparty exposure, particularly in this environment of heightened credit uncertainty."

To learn more about CME Group's OTC clearing offering, visit our resources on IRS and CDS.

As the world's leading and most diverse derivatives marketplace, CME Group (www.cmegroup.com) is where the world comes to manage risk.  CME Group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.  CME Group brings buyers and sellers together through its CME Globex® electronic trading platform and its trading facilities in New York and Chicago.  CME Group also operates CME Clearing, one of the world's leading central counterparty clearing providers, which offers clearing and settlement services for exchange-traded contracts, as well as for over-the-counter derivatives transactions through CME ClearPort®. These products and services ensure that businesses everywhere can substantially mitigate counterparty credit risk in both listed and over-the-counter derivatives markets.

CME Group is a trademark of CME Group Inc. The Globe Logo, CME, Globex and Chicago Mercantile Exchange are trademarks of Chicago Mercantile Exchange Inc.  CBOT and the Chicago Board of Trade are trademarks of the Board of Trade of the City of Chicago, Inc.  NYMEX, New York Mercantile Exchange and ClearPort are registered trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc.  All other trademarks are the property of their respective owners. Further information about CME Group (NASDAQ: CME) and its products can be found at www.cmegroup.com

CME-G

SOURCE CME Group

Corporate Communications

+1 312 930 3434
Email